0001209191-20-005643.txt : 20200130 0001209191-20-005643.hdr.sgml : 20200130 20200130180322 ACCESSION NUMBER: 0001209191-20-005643 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200130 FILED AS OF DATE: 20200130 DATE AS OF CHANGE: 20200130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUNLEVIE BRUCE CENTRAL INDEX KEY: 0001190211 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39203 FILM NUMBER: 20562638 MAIL ADDRESS: STREET 1: 2480 SAND HILL ROAD STREET 2: SUITE 200 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 1Life Healthcare Inc CENTRAL INDEX KEY: 0001404123 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760707204 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 1900 CITY: San Francisco STATE: CA ZIP: 94111 BUSINESS PHONE: 415-658-6792 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 1900 CITY: San Francisco STATE: CA ZIP: 94111 FORMER COMPANY: FORMER CONFORMED NAME: 1life Healthcare Inc DATE OF NAME CHANGE: 20070621 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-01-30 0 0001404123 1Life Healthcare Inc ONEM 0001190211 DUNLEVIE BRUCE C/O BENCHMARK 2965 WOODSIDE ROAD WOODSIDE CA 94062 1 0 1 0 Common Stock 187000 I See Footnote Series B Preferred Stock Common Stock 5749630 I See Footnote Series C Preferred Stock Common Stock 3736192 I See Footnote Series D Preferred Stock Common Stock 3046168 I See Footnote Series E Preferred Stock Common Stock 679393 I See Footnote Series G Preferred Stock Common Stock 220217 I See Footnote Warrant (Right to Buy) 6.5858 2020-10-03 Series G Preferred Stock 11010 I See Footnote Securities held by Benchmark Capital Partners V, L.P. ("BCP V"), as nominee for BCP V, Benchmark Founders' Fund V, L.P. ("BFF V"), Benchmark Founders' Fund V-A, L.P. ("BFF V-A"), Benchmark Founders' Fund V-B, L.P. ("BFF V-B"), and related individuals. Benchmark Capital Management Co. V, L.L.C. ("BCMC V"), the general partner of BCP V, BFF V, BFF V-A and BFF V-B, may be deemed to have sole voting and dispositive power over the securities. Bruce W. Dunlevie, a member of the Issuer's board of directors, Alexandre Balkanski, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Robert C. Kagle, Mitchell H. Lasky and Steven M. Spurlock are the managing members of BCMC V, and each of them may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of the securities, except to the extent of such person or entity's pecuniary interest in such securities. Each share of Issuer's Preferred Stock will automatically convert into an equal number of shares of Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date. Shares subject to the warrant are immediately exercisable. This report is one of three reports, each on a separate Form 3, but relating to the same holdings being filed by entities affiliated with Benchmark and their applicable members. /s/ Steven M. Spurlock, by power of attorney for Bruce W. Dunlevie 2020-01-30